• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconFDA

FDA

Page 4 of 35
A woman injects herself with medication.
HealthOzempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’
By Lindsey LeakeFebruary 11, 2025
A young woman undergoes a brain scan.
HealthMeet the 24-year-old helping Lilly test a preventive Alzheimer’s drug
By Lindsey LeakeFebruary 6, 2025
A person stands on a scale.
HealthHims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
By Lindsey LeakeFebruary 3, 2025
Close-up view of man in blue button-down shirt placing pills in his hand.
HealthNew pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids
By Bloomberg and Gerry SmithJanuary 31, 2025
The increase in online searches for obesity management drugs in recent years correlated to a surge in dispensed prescriptions, according to a new study from the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease.
HealthOnline searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next
By Lindsey LeakeJanuary 29, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
HealthHate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
By Lindsey LeakeJanuary 21, 2025
woman pouring milk from one container into another outside, with a cow in the background
HealthRaw milk, touted by RFK Jr. and costing up to $21 a gallon, is under fire because of bird flu. What science says about the benefits and risks
By Beth GreenfieldJanuary 17, 2025
A pile of candy hearts with messages written on them for Valentine's Day
HealthWhat foods have Red dye 3? Candy Corn, red icing, and other favorite snacks
By The Associated Press and Hallie SteinerJanuary 16, 2025
FDA bans red dye No. 3 from foods, supplements, and some medicines because of potential cancer risk
HealthFDA bans red dye No. 3 from foods, supplements, and some medicines because of potential cancer risk
By The Associated PressJanuary 15, 2025
Modern-day hippie moms have found solace in one Trump appointee: RFK Jr.
LifestyleModern-day hippie moms have found solace in one Trump appointee: RFK Jr.
By Sydney LakeDecember 4, 2024
The companies betting on male birth control step closer to approval—and into an uncertain political chapter
NewslettersThe companies betting on male birth control step closer to approval—and into an uncertain political chapter
By Nina AjemianNovember 29, 2024
Trump taps a Fox News personality, a surgeon and a former congressman to lead public health agencies
PoliticsTrump taps a Fox News personality, a surgeon and a former congressman to lead public health agencies
By Matthew Perrone, Amanda Seitz and The Associated PressNovember 23, 2024
Robert F. Kennedy Jr. standing in front of a podium with Donald Trump looking on behind him.
PoliticsEven if RFK Jr. fires everyone at the FDA, it won’t matter because he doesn’t know anyone with the ‘technical expertise’ to alter the rules, former chief counsel says
By Sasha RogelbergNovember 15, 2024
FDA announces new rules to make TV drug ads clearer as Trump nominates RFK Jr., who wants to ban them
HealthFDA announces new rules to make TV drug ads clearer as Trump nominates RFK Jr., who wants to ban them
By Matthew Perrone and The Associated PressNovember 15, 2024
Vinod Khosla pleads with Elon Musk after Trump’s win, begging for better regulation of the FDA rather than ‘RFK kooky science’
PoliticsVinod Khosla pleads with Elon Musk after Trump’s win, begging for better regulation of the FDA rather than ‘RFK kooky science’
By Alena BotrosNovember 11, 2024
1
  • 2
  • 3
  • 4
  • 5
  • 6
...35
Most Popular
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regretsplaceholder alt text
By Preston ForeApril 27, 2026
Economy
Jamie Dimon gets candid about national debt: ‘There will be a bond crisis, and then we’ll have to deal with it’placeholder alt text
By Eleanor PringleApril 29, 2026
Banking
‘They left me no choice’: Powell isn’t going anywhere—blocking Trump from another Fed appointeeplaceholder alt text
By Eva RoytburgApril 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.